Short-Term Application of Tocilizumab Following Myocardial Infarction
Phase of Trial: Phase III
Latest Information Update: 20 Nov 2017
At a glance
- Drugs Tocilizumab (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions
- Acronyms STAT-MI
- 31 Aug 2018 Biomarkers information updated
- 22 Oct 2017 Status changed from recruiting to completed.
- 29 Aug 2016 Planned End Date changed from 1 May 2017 to 1 Jun 2017.